Bad Surprises Kill Deals: What Closes Life Sciences & Medtech M&A w/ Gregg Blake | This Is M&A

Most medtech deals that stall were already in trouble before the process started. In this episode of This Is M&A, Gregg Blake, Managing Director in Healthcare Investment Banking at CapM Advisors, breaks down what separates deals that close from deals that die: how to build for a premium exit 2 to 3 years out, what hidden risks quietly kill momentum, and how to run a sell-side process that actually extracts maximum value at the finish line. Gregg Blake is a Managing Director at CapM Advisors, based in New York. He has been advising clients worldwide in healthcare, life science, and medical technology for over 20 years. He founded Brocair, a dedicated healthcare corporate finance advisor, in 2004 and ran it for over a decade before merging it with Bryan Garnier, where he co-led the healthcare practice. CapM Advisors has completed M&A transactions totaling over $51 billion. In this episode, you will learn: ⚡️ What the best companies do 2 to 3 years before exit to position for a premium outcome ⚡️ Why customer concentration and CEO dependency quietly destroy deal value before a buyer ever shows up ⚡️ How to control the diligence narrative before a buyer controls it for you ⚡️ Why running your own QofE before going to market is non-negotiable ⚡️ How competitive tension in a sell-side process added 25% to one deal's value in 36 hours ⚡️ When scientific risk kills life science deals versus when commercial risk is the real threat Learn more about Gregg Blake and CapM Advisors:  Website: https://cap-m.com  LinkedIn: https://linkedin.com/in/greggblake/ Connect with your host, Steven Monterroso:  LinkedIn: https://linkedin.com/in/determined2succeed/ Follow This Is M&A Podcast on LinkedIn: https://linkedin.com/company/this-is-m-a/ Want to become our next guest?  Sign up: https://sharevault.com/this-is-ma/ Listen now on Apple Podcasts, iHeartRadio and Spotify. Chapter Markers 00:00 — Meet Gregg Blake, M&A Insider  02:36 — Build the Exit Before It Exists  06:22 — Who You Take Money From Matters  11:03 — Capital Structure Can Kill Your Exit  14:05 — Why Deals Stall (And How to Stop It)  18:33 — Science Risk vs. Commercial Risk  21:30 — Management Red Flags Buyers Notice  23:44 — Creating Competitive Tension to Win  33:40 — Long-Term Relationships Drive Deals  39:45 — How to Reach Gregg Blake #thisismapodcast #mna #medtech #lifesciences #healthcareinvestmentbanking #exitplanning #founders #duediligence #middlemarket #dealstructure